James W. Dear - Concepedia

Author

James W. Dear

Also Known As

Alastair Crosswaite, Dear, James W, Dear, James W., J DEAR, J Dear, J W Dear, J. Dear, J. W. Dear, J.W. Dear, James Dear

291

Publications

12.8K

Citations

H-Index

132

Concepts

All Affiliations

University of Edinburgh The Queen's Medical Research Institute Edinburgh Royal Infirmary British Heart Foundation University of Liverpool

About

James W. Dear is an author at University of Edinburgh specializing in medicine, pharmacology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	23	31	3.9K
2	Engineering	9	9	948
3	Health Sciences	2	2	46
4	Education	1	1	84
5	Natural Sciences	1	1	170

James W. Dear

Publications

9.3K

Citations

H-Index

Page 1

	Year	Citations
Collection, storage, preservation, and normalization of human urinary exosomes for biomarker discovery Hou‐De Zhou, Peter S.T. Yuen, Trairak Pisitkun, Kidney International EngineeringMedicineBiomarker TargetBioanalysisHuman Urinary Exosomes	2006	588
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Eugenia Abaleke, Mustafa Abbas, Sadia Abbasi, The Lancet Long CovidAntimicrobial StewardshipAntibioticsClinical InfectionPlatform Trial	2021	555
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial Obbina Abani, Ali Abbas, Fatima Abbas, The Lancet	2021	516
Circulating microRNAs as potential markers of human drug-induced liver injury Philip J. Starkey Lewis, James W. Dear, Vivien Platt, Hepatology	2011	513
Identification and proteomic profiling of exosomes in human cerebrospinal fluid Jonathan M. Street, Perdita E. Barran, C. Logan Mackay, Journal of Translational Medicine	2012	460
Blood Kidney Injury Molecule-1 Is a Biomarker of Acute and Chronic Kidney Injury and Predicts Progression to ESRD in Type I Diabetes Venkata Sabbisetti, Sushrut S. Waikar, Daniel J. Antoine, Journal of the American Society of Nephrology ImmunologyPredicts ProgressionPathologyKidney InjuryInflammation	2014	444
Mechanistic Biomarkers Provide Early and Sensitive Detection of Acetaminophen-Induced Acute Liver Injury at First Presentation to Hospital Daniel J. Antoine, James W. Dear, Philip Starkey Lewis, Hepatology	2013	424
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Obbina Abani, Ali Abbas, Fatima Abbas, The Lancet Covid-19 PandemicAntiviral TherapyClinical TrialsPlatform TrialMedicine	2022	382
Urinary extracellular vesicles: A position paper by the Urine Task Force of the International Society for Extracellular Vesicles Uta Erdbrügger, Charles J. Blijdorp, Irene V. Bijnsdorp, Journal of Extracellular Vesicles	2021	370
Long-term cardiovascular safety of febuxostat compared with allopurinol in patients with gout (FAST): a multicentre, prospective, randomised, open-label, non-inferiority trial Isla S. Mackenzie, Ian Ford, George Nuki, The Lancet Cardiovascular DiseaseGouty ArthritisPharmacotherapyNon-inferiority TrialMedicine	2020	322

Page 1